REFERENCES
- Summary Report: NHLI's Blood Resource Studies. Publication (NIH) 73–416, Department of Health, Education, and Welfare, June 30, 1972, p 109
- Schmer G, Kirby EP, Teller DC, et al: The isolation and characterization of bovine factor VIII (antihemophilic factor). J Biol Chem 247:2512, 1972
- Barrow EM, Graham JB: Factor VIII. Lancet 1:1312–1313, 1973
- Michael SE, Tunnah GW: The purification of factor VIII (AHG). Br J Haematol 12:115–132, 1966
- Gardikas Cf Bakaloudis P, Hatzioannou J, et al: The factor VIII concentration of the hepatic venous blood. Br J Haematol 11:380–381, 1965
- Webster WP, Zukoski CF, Hutchin P, et al: Plasma factor VIII synthesis and control as revealed by canine organ transplantation. Am J Physiol 220: 1147–1154, 1971
- Zimmerman TS, Ratnoff OD, Powell, AE: Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand's disease, with observation on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor. J Clin Invest 50:244–254, 1971
- Zimmerman TS, Ratnoff OD, Littell AS: Detection of carriers of classic hemophilia using an immunologic assay for antihemophilic factor (factor VIII). J Clin Invest 50:255–258, 1971
- Salzman EW: Measurement of platelet adhesiveness: A simple in vitro technique demonstrating an abnormality in von Willebrand's disease. J Lab Clin Med 62:724–735, 1963
- Howard MA, Sawers RJ, Firkin BG: Ristocetin: A means of differentiating von Willebrand's disease into two groups. Blood 41:687–690, 1973
- Weiss HJ, Rogers J, Brand H: Properties of the platelet retention (von Willebrand) factor and its similarity to the antihemophilic factor (AHF). Blood 41:809–815, 1973
- Cornu P, Larrieu MJ, Caen J, et al: Transfusion studies in von Willebrand's disease: Effect on bleeding time and factor VIII. Br J Haematol 9:189–202, 1963
- Rizza CR: The management of patients with coagulation factor deficiencies. In Biggs R (Editor): Human Blood Coagulation, Haemostasis, and Thrombosis. Oxford, Eng, Blackwell Scientific Publications Ltd, 1972, p 341
- Walsh PN, Rizza CR, Matthews JM, et al: Epsilon- aminocaproic acid therapy for dental extractions in haemophilia and Christmas disease: A double-blind controlled trial. Br J Haematol 20:463–475, 1971
- Storti E, Ascari E, Turpini R, et al: Epsilon-aminocaproic acid for synovectomy in hemophilic patients. Acta Haematol (Basel) 47:146–156, 1972
- Kisker CT, Burke C: Double-blind studies on the use of steroids in the treatment of acute hemar- throsis in patients with hemophilia. N Engl J Med 282:639–642, 1970
- Rabiner SF, Telfer MC: Home transfusions for patients with hemophilia A. N Engl J Med 283:1011–1015, 1970
- Brinkhous KM, Carney CN, Sherman RW: Use of high-potency antihemophilic factor concentrates in prophylaxis. Thromb Diath Haemorrh Suppl 43: 139–147, 1971
- Green D: Therapeutic materials. In Green D (Editor): Hemophilia, a Manual of Outpatient Management. Springfield, Ill, Charles C Thomas, 1973
- Strauss HS: Acquired circulating anticoagulants in hemophilia A. N Engl J Med 281:866–873, 1969
- Nilsson IM, Hedner U, Björlin G: Suppression of factor IX antibody in hemophilia B by factor IX and cyclophosphamide. Ann Intern Med 78:91–95, 1973
- Roberts HR, Scales MB, Madison JT, et al: A clinical and experimental study of acquired inhibitors to factor VIII. Blood 26:805–818, 1965
- Edson JR, McArthur JR, Branda RF, et al: Successful management of a subdural hematoma in a hemophiliac with an anti-factor VIII antibody. Blood 41:113–122, 1973